Viagra Malaysia treat erectile dysfunction with the original ED treatment that has helped men feel confident in bed for decades. We’ll connect you with a licensed healthcare provider to evaluate if viagra malaysia our prescription ED treatments could be right for you, including super-affordable generic Viagra viagramalaysiaofficial Viagra is an oral ED medication that works by suppressing an enzyme in the body called PDE5.

Follow Us! Like Our Page!

Canntab Announces Appointment of Richard Goldstein as Interim CEO

Press Release

TORONTO, August 22nd, 2022/ – Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab“), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provide an update on its recent product delivery of our unique pharmaceutical cannabinoid solutions to the Nova Scotia Liquor Corporation (the “NSLC”).

On August 15th, 2022, Canntab completed its first shipment of 5mg and 10mg THC InstaCann tablets to the NSLC, totaling 300 bottles of each SKU. These products are now available on the NSLC’s online platform and will be available in their brick-and-mortar stores starting today, August 22nd, 2022.

“This is a continuation of our efforts to expand our sphere of influence across not only Ontario, but the rest of the Canadian provinces,” says Richard Goldstein, co-founder, CFO, and interim CEO. Mr. Goldstein continues, “while we have our online ecommerce store open for our medical patients, getting into more retail locations while also being listed with the NSLC’s online platform is another positive move for Canntab. We are leaders in the oral delivery system of cannabis in the market today.”

About Canntab Therapeutics Limited

Canntab is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Long referred to as Cannabis 3.0 by the Company, Canntab’s proprietary hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions which incorporate all the features one would expect from any prescription or over the counter medication sold in pharmacies around the world. These include once a day and extended-release formulations, both providing an accurate dose and improved shelf stability.

Canntab holds a Cannabis Standard Processing & Sales for Medical Purposes License and a Cannabis Research License.

Canntab trades on the Canadian Securities Exchange under the symbol PILL, on the OTCQB under the symbol CTABF, and on the Frankfurt Stock Exchange under the symbol TBF1.

Canntab Therapeutics Limited

Richard Goldstein
Chief Financial Officer &
Interim Chief Executive Officer
+1 833 301-3812
[email protected]

IBF4

 76 total views,  2 views today

NationTalk Partners & Sponsors Learn More